QQQ   431.63 (+0.13%)
AAPL   172.70 (+0.01%)
MSFT   416.72 (+0.74%)
META   503.73 (+0.70%)
GOOGL   154.84 (-0.01%)
AMZN   183.86 (+0.13%)
TSLA   155.03 (-3.99%)
NVDA   873.70 (+1.59%)
AMD   162.80 (+1.55%)
NIO   3.79 (-2.57%)
BABA   69.63 (-1.40%)
T   16.06 (-1.11%)
F   12.10 (-1.06%)
MU   119.46 (-1.57%)
GE   154.98 (+0.83%)
CGC   6.73 (-3.58%)
DIS   112.92 (-0.03%)
AMC   2.49 (+0.81%)
PFE   25.85 (-0.23%)
PYPL   63.20 (-0.49%)
XOM   119.07 (-0.51%)
QQQ   431.63 (+0.13%)
AAPL   172.70 (+0.01%)
MSFT   416.72 (+0.74%)
META   503.73 (+0.70%)
GOOGL   154.84 (-0.01%)
AMZN   183.86 (+0.13%)
TSLA   155.03 (-3.99%)
NVDA   873.70 (+1.59%)
AMD   162.80 (+1.55%)
NIO   3.79 (-2.57%)
BABA   69.63 (-1.40%)
T   16.06 (-1.11%)
F   12.10 (-1.06%)
MU   119.46 (-1.57%)
GE   154.98 (+0.83%)
CGC   6.73 (-3.58%)
DIS   112.92 (-0.03%)
AMC   2.49 (+0.81%)
PFE   25.85 (-0.23%)
PYPL   63.20 (-0.49%)
XOM   119.07 (-0.51%)
QQQ   431.63 (+0.13%)
AAPL   172.70 (+0.01%)
MSFT   416.72 (+0.74%)
META   503.73 (+0.70%)
GOOGL   154.84 (-0.01%)
AMZN   183.86 (+0.13%)
TSLA   155.03 (-3.99%)
NVDA   873.70 (+1.59%)
AMD   162.80 (+1.55%)
NIO   3.79 (-2.57%)
BABA   69.63 (-1.40%)
T   16.06 (-1.11%)
F   12.10 (-1.06%)
MU   119.46 (-1.57%)
GE   154.98 (+0.83%)
CGC   6.73 (-3.58%)
DIS   112.92 (-0.03%)
AMC   2.49 (+0.81%)
PFE   25.85 (-0.23%)
PYPL   63.20 (-0.49%)
XOM   119.07 (-0.51%)
QQQ   431.63 (+0.13%)
AAPL   172.70 (+0.01%)
MSFT   416.72 (+0.74%)
META   503.73 (+0.70%)
GOOGL   154.84 (-0.01%)
AMZN   183.86 (+0.13%)
TSLA   155.03 (-3.99%)
NVDA   873.70 (+1.59%)
AMD   162.80 (+1.55%)
NIO   3.79 (-2.57%)
BABA   69.63 (-1.40%)
T   16.06 (-1.11%)
F   12.10 (-1.06%)
MU   119.46 (-1.57%)
GE   154.98 (+0.83%)
CGC   6.73 (-3.58%)
DIS   112.92 (-0.03%)
AMC   2.49 (+0.81%)
PFE   25.85 (-0.23%)
PYPL   63.20 (-0.49%)
XOM   119.07 (-0.51%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$18.47
-2.0%
$19.34
$17.24
$31.31
$853.31M0.96284,461 shs8,839 shs
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$50.64
-0.7%
$46.09
$16.96
$77.55
$1.38B1.24434,670 shs14,974 shs
Inogen, Inc. stock logo
INGN
Inogen
$6.99
-2.4%
$7.70
$4.13
$14.10
$163.08M1.06579,762 shs11,896 shs
Sientra, Inc. stock logo
SIEN
Sientra
$0.17
-18.7%
$0.45
$0.16
$4.94
$2.08M2.044.15 million shs3.44 million shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
+1.84%-3.43%-1.26%-1.52%-36.77%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
+0.53%-5.85%+4.13%+46.95%-30.37%
Inogen, Inc. stock logo
INGN
Inogen
-2.72%+11.35%+3.77%+32.59%-44.02%
Sientra, Inc. stock logo
SIEN
Sientra
0.00%0.00%0.00%-70.22%-89.06%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
3.9042 of 5 stars
3.34.00.00.02.83.32.5
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
0.7042 of 5 stars
2.50.00.00.01.92.50.6
Inogen, Inc. stock logo
INGN
Inogen
4.0186 of 5 stars
3.04.00.03.91.91.71.3
Sientra, Inc. stock logo
SIEN
Sientra
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
2.50
Moderate Buy$31.0067.84% Upside
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
3.00
Buy$63.3325.07% Upside
Inogen, Inc. stock logo
INGN
Inogen
2.00
Hold$13.6795.52% Upside
Sientra, Inc. stock logo
SIEN
Sientra
2.00
HoldN/AN/A

Current Analyst Ratings

Latest INGN, AVNS, ESTA, and SIEN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/9/2024
Inogen, Inc. stock logo
INGN
Inogen
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
4/3/2024
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$49.00 ➝ $60.00
4/1/2024
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$50.00 ➝ $65.00
2/29/2024
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$46.00 ➝ $53.00
2/15/2024
Inogen, Inc. stock logo
INGN
Inogen
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
(Data available from 4/16/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$673.30M1.27$2.02 per share9.15$26.63 per share0.69
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$165.15M8.34N/AN/A$0.71 per share71.32
Inogen, Inc. stock logo
INGN
Inogen
$315.66M0.52N/AN/A$8.79 per share0.80
Sientra, Inc. stock logo
SIEN
Sientra
$90.55M0.02N/AN/A($0.04) per share-4.35

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
-$61.80M-$1.32N/A10.041.08-8.76%4.25%3.11%5/1/2024 (Estimated)
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$78.50M-$3.04N/AN/AN/A-47.53%-357.81%-30.37%5/13/2024 (Estimated)
Inogen, Inc. stock logo
INGN
Inogen
-$102.45M-$4.41N/AN/AN/A-32.46%-38.98%-27.03%5/7/2024 (Confirmed)
Sientra, Inc. stock logo
SIEN
Sientra
-$73.31M-$5.57N/AN/AN/A-65.93%N/A-40.45%N/A

Latest INGN, AVNS, ESTA, and SIEN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Inogen, Inc. stock logo
INGN
Inogen
-$0.76N/A+$0.76N/AN/AN/A  
2/28/2024Q4 2023
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$0.95-$0.79+$0.16-$0.79$31.44 million$31.60 million      
2/27/2024Q4 2023
Inogen, Inc. stock logo
INGN
Inogen
-$0.65-$1.14-$0.49-$1.14$78.09 million$75.90 million
2/20/202412/31/2023
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
$0.37$0.36-$0.01$0.49$170.43 million$173.30 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
N/AN/AN/AN/AN/A
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
N/AN/AN/AN/AN/A
Inogen, Inc. stock logo
INGN
Inogen
N/AN/AN/AN/AN/A
Sientra, Inc. stock logo
SIEN
Sientra
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
0.13
2.08
1.38
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
10.26
3.06
1.67
Inogen, Inc. stock logo
INGN
Inogen
N/A
2.86
2.55
Sientra, Inc. stock logo
SIEN
Sientra
N/A
0.57
0.31

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
95.17%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
72.91%
Inogen, Inc. stock logo
INGN
Inogen
89.94%
Sientra, Inc. stock logo
SIEN
Sientra
15.38%

Insider Ownership

CompanyInsider Ownership
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
3.94%
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
12.64%
Inogen, Inc. stock logo
INGN
Inogen
0.64%
Sientra, Inc. stock logo
SIEN
Sientra
1.53%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Avanos Medical, Inc. stock logo
AVNS
Avanos Medical
3,77146.20 million44.38 millionOptionable
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
90827.20 million23.77 millionOptionable
Inogen, Inc. stock logo
INGN
Inogen
83423.33 million23.18 millionOptionable
Sientra, Inc. stock logo
SIEN
Sientra
30411.96 million11.78 millionOptionable

INGN, AVNS, ESTA, and SIEN Headlines

SourceHeadline
Aesthetic Implants Market: In-Depth Analysis, Emerging Trends, Growth Drivers, and Forecasts up to 2033Aesthetic Implants Market: In-Depth Analysis, Emerging Trends, Growth Drivers, and Forecasts up to 2033
pharmiweb.com - April 13 at 7:57 AM
Breast Implants Market to Reach USD 7.8 Billion by 2032, CAGR 6.7% | Marketresearch.bizBreast Implants Market to Reach USD 7.8 Billion by 2032, CAGR 6.7% | Marketresearch.biz
pharmiweb.com - April 12 at 5:47 AM
Nasdaq (NDAQ) Initiated with a Buy at BarclaysNasdaq (NDAQ) Initiated with a Buy at Barclays
markets.businessinsider.com - April 11 at 7:34 AM
Sientra (NASDAQ:SIEN) Now Covered by StockNews.comSientra (NASDAQ:SIEN) Now Covered by StockNews.com
americanbankingnews.com - April 11 at 2:18 AM
Medical Aesthetics Market Future Projections: USD 51.7 Billion By 2032 With A Consistent 14.7% Growth RateMedical Aesthetics Market Future Projections: USD 51.7 Billion By 2032 With A Consistent 14.7% Growth Rate
pharmiweb.com - April 8 at 4:33 PM
Global Extremity Tissue Expanders Industry Expected to Grow at a Startling 6.3% CAGR to Reach US$ 1,842.6 Million by 2028 | FMI AnalysisGlobal Extremity Tissue Expanders Industry Expected to Grow at a Startling 6.3% CAGR to Reach US$ 1,842.6 Million by 2028 | FMI Analysis
fmiblog.com - April 4 at 6:23 PM
Aesthetic Implants Market on Track for Remarkable Expansion, Forecasted to Surpass USD 10 Billion by 2032 | Market.usAesthetic Implants Market on Track for Remarkable Expansion, Forecasted to Surpass USD 10 Billion by 2032 | Market.us
pharmiweb.com - April 4 at 8:22 AM
Sientra Sells Business Parts for $50M+Sientra Sells Business Parts for $50M+
ocbj.com - April 3 at 3:53 PM
Sientra, Inc.: Sientra Announces Completion and Winning Bidders of its Section 363 Sales AuctionSientra, Inc.: Sientra Announces Completion and Winning Bidders of its Section 363 Sales Auction
finanznachrichten.de - April 3 at 10:53 AM
Nuance Medical Agrees to Acquire BIOCORNEUM Scar Treatment BrandNuance Medical Agrees to Acquire BIOCORNEUM Scar Treatment Brand
finance.yahoo.com - April 3 at 10:53 AM
Sientra Announces Completion and Winning Bidders of its Section 363 Sales AuctionSientra Announces Completion and Winning Bidders of its Section 363 Sales Auction
globenewswire.com - April 2 at 6:30 PM
Global Gynecomastia Procedures Market Size To Exceed USD 1900 Million by 2033 | CAGR Of 8.05%Global Gynecomastia Procedures Market Size To Exceed USD 1900 Million by 2033 | CAGR Of 8.05%
finance.yahoo.com - March 15 at 4:23 AM
Global Cosmetic Implants Market, with a special focus on dental implants, is anticipated to hit a remarkable US$ 17.9 Billion by 2032Global Cosmetic Implants Market, with a special focus on dental implants, is anticipated to hit a remarkable US$ 17.9 Billion by 2032
fmiblog.com - March 14 at 11:23 PM
Firm Retention Summary: SientraFirm Retention Summary: Sientra
wsj.com - March 7 at 3:39 PM
Sientra Declares Bankruptcy, Seeks BuyerSientra Declares Bankruptcy, Seeks Buyer
ocbj.com - February 26 at 7:00 PM
Global Extremity Tissue Expanders Industry Poised for a Meteoric Rise, Anticipating US$ 1,842.6 Million with a Resounding 6.3% CAGR by 2028 | FMIGlobal Extremity Tissue Expanders Industry Poised for a Meteoric Rise, Anticipating US$ 1,842.6 Million with a Resounding 6.3% CAGR by 2028 | FMI
fmiblog.com - February 21 at 3:22 PM
SIEN Mar 2024 2.500 callSIEN Mar 2024 2.500 call
finance.yahoo.com - February 17 at 8:46 AM
Sientra, Inc.: Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 ProcessSientra, Inc.: Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
finanznachrichten.de - February 15 at 3:24 PM
Plastic surgery company goes bust, files Chapter 11 bankruptcyPlastic surgery company goes bust, files Chapter 11 bankruptcy
msn.com - February 15 at 3:24 PM
Plastic-surgery company goes bust, files Chapter 11 bankruptcyPlastic-surgery company goes bust, files Chapter 11 bankruptcy
msn.com - February 15 at 10:23 AM
Implant Maker Sientra Cleared to Draw Deerfield Bankruptcy LoanImplant Maker Sientra Cleared to Draw Deerfield Bankruptcy Loan
msn.com - February 14 at 6:42 PM
Health Care Limits Losses Amid Defensive Bias -- Health Care RoundupHealth Care Limits Losses Amid Defensive Bias -- Health Care Roundup
marketwatch.com - February 13 at 8:34 PM
Breast-Implant Maker Sientra Files for BankruptcyBreast-Implant Maker Sientra Files for Bankruptcy
wsj.com - February 13 at 8:34 PM
Sientra Files For Bankruptcy Amid $82 Million DebtSientra Files For Bankruptcy Amid $82 Million Debt
usaherald.com - February 13 at 3:34 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Avanos Medical logo

Avanos Medical

NYSE:AVNS
Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Establishment Labs logo

Establishment Labs

NASDAQ:ESTA
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Inogen logo

Inogen

NASDAQ:INGN
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Sientra logo

Sientra

NASDAQ:SIEN
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Irvine, California. On February 12, 2024, Sientra, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.